Going global – Travel and the 2019 novel coronavirus

Travel Medicine and Infectious Disease

Volumn 33, Issue , 2020, Pages

  Rodríguez Morales, Alfonso J ^a,b   MacGregor, Kirsten ^c   Kanagarajah, Sanch ^c   Patel, Dipti ^c   Schlagenhauf, Patricia ^d  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^b FACULTY OF MEDICINE   (Colombia)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

2019 nCoV; Coronaviruses; Epidemic; Travelers

Indexed keywords

CHINA; CORONAVIRUS DISEASE 2019; DEATH; EDITORIAL; EPIDEMIC; EUROPE; GLOBAL HEALTH; HUMAN; INTERNATIONAL HEALTH REGULATION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOUTH AND CENTRAL AMERICA; TRAVEL; UNITED KINGDOM; UNITED STATES; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; BETACORONAVIRUS; CORONAVIRUS INFECTION; EMPORIATRICS; INFECTION CONTROL; INTERPERSONAL COMMUNICATION; PATHOGENICITY; PRACTICE GUIDELINE; VIRUS PNEUMONIA;

COVID-19; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;

BETACORONAVIRUS; COMMUNICATION; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; EUROPE; GLOBAL HEALTH; GUIDELINES AS TOPIC; HUMANS; INFECTION CONTROL; LATIN AMERICA; PNEUMONIA, VIRAL; TRAVEL; TRAVEL MEDICINE; UNITED KINGDOM; UNITED STATES;

EID: 85079170254     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2020.101578     Document Type: Editorial

References (50)

1. World Health Organization, Statement on the second meeting of the International Health Regulations, Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2005, 2020 https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov.
2. World Health Organization, Novel coronavirus (2019-nCoV) - situation report - 10 - 30 January 2020., 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2.
3. Rodriguez-Morales, A.J., Bonilla-Aldana, D.K., Balbin-Ramon, G.J., Paniz-Mondolfi, A., Rabaan, A., Sah, R., et al. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus. Infez Med 28 (2020), 3–5.
4. Gumel, A.B., Ruan, S., Day, T., Watmough, J., Brauer, F., van den Driessche, P., et al. Modelling strategies for controlling SARS outbreaks. Proc Biol Sci 271 (2004), 2223–2232.
5. Rahman, A., Sarkar, A., Risk factors for fatal Middle East respiratory syndrome coronavirus infections in Saudi Arabia: analysis of the WHO line list, 2013-2018. Am J Publ Health 109 (2019), 1288–1293.
6. Cui, J., Li, F., Shi, Z.L., Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17 (2019), 181–192.
7. Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003), 450–454.
8. Qian, Z., Travanty, E.A., Oko, L., Edeen, K., Berglund, A., Wang, J., et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol 48 (2013), 742–748.
9. Wu, F., Zhao, S., Yu, B., Chen, Y.M., Wang, W., Song, Z.G., et al. A new coronavirus associated with human respiratory disease in China. Nature, 2020, 10.1038/s41586-020-2008-3.
10. Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 10.1038/s41586-020-2012-7.
11. Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500 (2013), 227–231.
12. Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H., Muller, M.A., Dijkman, R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495 (2013), 251–254.
13. Scobey, T., Yount, B.L., Sims, A.C., Donaldson, E.F., Agnihothram, S.S., Menachery, V.D., et al. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 110 (2013), 16157–16162.
14. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 10.1016/S0140-6736(20)30183-5.
15. Biscayart, C., Angeleri, P., Lloveras, S., Chaves, T., Schlagenhauf, P., Rodriguez-Morales, A.J., The next big threat to global health? 2019 novel coronavirus (2019-nCoV): what advice can we give to travellers? - interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI). Trav Med Infect Dis, 2020, 101567, 10.1016/j.tmaid.2020.101567.
16. Bonilla-Aldana, D.K., Quintero-Rada, K., Montoya-Posada, J.P., Ramirez, S., Paniz-Mondolfi, A., Rabaan, A., et al. SARS-CoV, MERS-CoV and now the 2019-novel CoV: have we investigated enough about coronaviruses? - a bibliometric analysis. Trav Med Infect Dis, 2020, 10.1016/j.tmaid.2020.101566 101566.
17. Zhao, S., Zhuang, Z., Ran, J., Lin, J., Yang, G., Yang, L., et al. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: a data-driven correlational report. Travel medicine and infectious disease, 2020, 10.1016/j.tmaid.2020.101568:101568.
18. Bogoch, Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M.U.G., Khan, K., Potential for global spread of a novel coronavirus from China. J Trav Med, 2020, 10.1093/jtm/taaa011.
19. Wilson, M.E., Chen, L.H., Travelers give wings to novel coronavirus (2019-nCoV). J Trav Med, 2020, 10.1093/jtm/taaa015.
20. Chan, J.F.-W., Yuan, S., Kok, K.-H., To, K.K.-W., Chu, H., Yang, J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 10.1016/S0140-6736(20)30154-9.
21. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 10.1016/S0140-6736(20)30211-7.
22. Phan, L.T., Nguyen, T.V., Luong, Q.C., Nguyen, T.V., Nguyen, H.T., Le, H.Q., et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med, 2020, 10.1056/NEJMc2001272.
23. Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med, 2020, 10.1056/NEJMc2001468.
24. ECDC, Novel coronavirus. 2020 https://www.ecdc.europa.eu/en/novel-coronavirus-china.
25. ECDC, ECDC statement following reported confirmed case of 2019-nCoV in Germany. 2020 https://www.ecdc.europa.eu/en/news-events/ecdc-statement-following-reported-confirmed-case-2019-ncov-germany.
26. ECDC, Advice to healthcare workers: management of patients with 2019-nCoV infection. 2020 https://www.ecdc.europa.eu/en/publications-data/advice-healthcare-workers-management-patients-2019-ncov-infection.
27. ECDC, Algorithm for management of contacts of probable or confirmed 2019-nCoV cases. 2020 https://www.ecdc.europa.eu/en/publications-data/algorithm-management-contacts-probable-or-confirmed-2019-ncov-cases.
28. ECDC, Infection prevention and control for the care of patients with 2019-nCoV in healthcare settings. 2020 https://www.ecdc.europa.eu/en/publications-data/infection-prevention-and-control-care-patients-2019-ncov-healthcare-settings.
29. ECDC, Public health management of persons having had contact with novel coronavirus cases in the European Union. 2020 https://www.ecdc.europa.eu/en/publications-data/public-health-management-persons-having-had-contact-novel-coronavirus-cases.
30. ECDC, Risk assessment: outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA − third update. 2020 https://www.ecdc.europa.eu/en/publications-data/risk-assessment-outbreak-acute-respiratory-syndrome-associated-novel-1.
31. World Tourism Organisation, International tourism highlights. 2019 Edition, 2019, UNWTO, Madrid, 10.18111/9789284421152.
32. Office for National Statistics, Travel trends estimates: overseas residents in the UK and UK residents abroad. 2020 https://www.ons.gov.uk/peoplepopulationandcommunity/leisureandtourism/datasets/travelandtourism.
33. World Health Organization, Pneumonia of unknown cause – China. 2020 https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en.
34. Public Health England, Novel coronavirus (2019-nCoV) - what you need to know. 2020 https://publichealthmatters.blog.gov.uk/2020/01/23/wuhan-novel-coronavirus-what-you-need-to-know.
35. GOV.UK. China travel advice. 2020 https://www.gov.uk/foreign-travel-advice/china.
36. GOV.UK. Health - China travel advice. https://www.gov.uk/foreign-travel-advice/china/health, 2020.
37. World Health Organization, Communicating risk in public health emergencies: a WHO guideline for emergency risk communication (ERC) policy and practice. 2017 https://www.who.int/risk-communication/guidance/download/en/.
38. Public Health England, Guidance - coronavirus: latest information and advice. 2020 https://www.gov.uk/guidance/wuhan-novel-coronavirus-information-for-the-public.
39. Public Health England, Guidance to assist professionals in advising the general public. 2020 https://www.gov.uk/government/publications/novel-coronavirus-2019-ncov-guidance-to-assist-professionals-in-advising-the-general-public/guidance-to-assist-professionals-in-advising-the-general-public.
40. CDC U, Novel coronavirus - information for healthcare professionals. 2019 2020 https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html.
41. Wilson, T.D., Introduction:The impacts of tourism in Latin America. Lat Am Perspect 35 (2008), 3–20.
42. Jenkins, R., China's global expansion and Latin America. J Lat Am Stud 42 (2011), 809–837.
43. Jenkins, R., Peters, E.D., Moreira, M.M., The impact of China on Latin America and the Caribbean. World Dev 36 (2008), 235–253.
44. Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., et al. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020, 10.1056/NEJMoa2001191.
45. Wang, C., Horby, P.W., Hayden, F.G., Gao, G.F., A novel coronavirus outbreak of global health concern. Lancet, 2020, 10.1016/S0140-6736(20)30185-9.
46. Cohen, J., New coronavirus threat galvanizes scientists. Science 367 (2020), 492–493.
47. Chu, C.M., Cheng, V.C., Hung, I.F., Wong, M.M., Chan, K.H., Chan, K.S., et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59 (2004), 252–256.
48. Arabi, Y.M., Asiri, A.Y., Assiri, A.M., Aziz Jokhdar, H.A., Alothman, A., Balkhy, H.H., et al. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials, 21, 2020, 8.
49. Arabi, Y.M., Alothman, A., Balkhy, H.H., Al-Dawood, A., AlJohani, S., Al Harbi, S., et al. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials, 19, 2018, 81.
50. Stoye, M., China coronavirus: how many papers have been published?. Nature, 2020, 10.1038/d41586-020-00253-8.